Jason E. Estes, serving as Executive Vice President and Chief Compliance Officer at Bank7 Corp. (NASDAQ:BSVN), conducted a sequence of equity transactions involving the company's stock on July 21 and 22, 2026. The aggregate value of these sales reached $247,668. The shares were disposed of at varying price points, with execution prices spanning from $48.2516 to $49.70. At the time of these transactions, the stock was trading at approximately $48.25, which corresponded to a market capitalization of $459 million for the regional bank. Valuation metrics indicated a price-to-earnings ratio of 10.94.
Analysis from InvestingPro suggested that Bank7's current valuation may be elevated relative to its fair value estimate. Despite this perspective, the stock had generated a 19% return for the year to date. The company has also demonstrated a commitment to shareholder returns, having increased its dividend for five consecutive years. The current dividend yield stands at 2.24%. Comprehensive analysis and additional insights are available through the detailed Pro Research Report for BSVN.
On July 21, 2026, Mr. Estes acquired 1,250 shares of Bank7 Corp. common stock. This acquisition was facilitated through the exercise of employee stock options, with an exercise price set at $14.31 per share, resulting in a total cost of $17,887. On the same day, he immediately disposed of these 1,250 shares at a price of $49.20. Additionally, Mr. Estes sold an further 1,975 shares at $49.70. The following day, July 22, 2026, the transaction activity continued with the sale of 1,824 shares. These shares were sold at a weighted average price of $48.2516, with the sales executed across multiple transactions at prices ranging from $48.25 to $49.75.
Following these recent trades, Mr. Estes's direct ownership of Bank7 Corp. common stock totaled 100,074 shares. This holding includes 2,047 restricted stock units that are scheduled to vest in three equal installments through July 2028. Furthermore, he holds 30,000 restricted stock units that will vest in eight equal installments through July 2033. The portfolio also contains 4,035 restricted stock units derived from an original grant of 6,052 units, which vest in three equal installments through February 2028. Additionally, there are 2,549 restricted stock units from an original grant of 7,647 units, vesting in three equal installments through February 2027. The employee stock options exercised were part of a broader grant of 5,000 options that vested in four equal installments between January 2022 and January 2025.
In the broader context of corporate performance, Bank7 reported its second-quarter 2026 earnings, which fell short of Wall Street expectations. The company reported earnings per share of $0.87 on revenue of $22.91 million. This performance missed the anticipated earnings of $1.04 per share and revenue of $23.86 million. However, the company benefited from a $3.7 million gain from oil and gas asset recovery, which helped offset the lower-than-expected results. Management emphasized the strength of core recurring results, highlighting a stable net interest margin and deposit costs.
Looking ahead, Bank7 anticipates elevated expenses in the third quarter due to IT remediation and merger-related costs. The company remains optimistic about loan fundings, describing the upcoming pipeline as robust. Additionally, Bank7 maintained a positive outlook on capital, liquidity, and future acquisition plans, including ongoing processes with Century Bank.